Specifically Deoxyribozyme of the PTPRO Gene as a Potential Gene Therapy Means for Human Hepatocellular Carcinoma

Article Preview

Abstract:

Protein tyrosine phosphatase receptor-type O (PTPRO) has been described in several forms of cancer as a new member of the PTP family. The tumor suppressor function of PTPRO was evaluated by design and synthesis the 10-23 deoxyribozyme (DRz), thio-modified DRz (DRz-s) and antisense oligonucleotide (asON) of the PTPRO genomic mRNA to detect the catalytic cleavage activity. Firstly, the cDNA fragment of PTPRO gene was amplified from total cellular RNA of the HepG2.2.15 cells by reverse transcription PCR (RT-PCR). Subsequently, the fragments were cloned to pcDNA3.1(+) plasmids and generated a recombinant plasmids, then sifted the positive recombinant plasmids out to amplify. The expression vector of PTPRO mRNA was obtained in vitro transcription by using T7 RNA polymerase. The results of transfection indicated that when PTPRO mRNA gamyed with deoxyribozyme which activity enhanced, so DRz-s were detected with more intensive specific catalytic cleavage activity than DRz by cells transfecting. And the asON wasn't detected with the property.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 781-784)

Pages:

1203-1208

Citation:

Online since:

September 2013

Authors:

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] R.G. Fahmy, A. Waldman, G. Zhang, A. Mitchell, N., Tedla, H., Cai C.R., Geczy, C.N., Chesterman, M., Perry, L.M. Khachigian, J. Nat. Biotechnol. Vol. 24(2006), p.856.

DOI: 10.1038/nbt1225

Google Scholar

[2] L. Yen, S.M. Strittmatter, R.G. Kalb, Ann. Neurol. Vol. 46(1999), p.366.

Google Scholar

[3] S. Chakraborti, A.C. Banerjea, Molec. Ther. Vol. 7(2003), p.817.

Google Scholar

[4] Z.X. Lu, Ye, M., Yan, G.R., Li, Q., Tang, M., Lee, L.M., Sun, L.Q., Y. Cao, Cancer Gene Ther. Vol. 12(2005), p.647.

Google Scholar

[5] H. Takahashi, Hamazaki, H., Habu, Y., Hayashi, M., Abe, T., Miyano-Kurosaki, N., H. Takaku, FEBS Lett. P. Vol. 560(2004), p.69.

DOI: 10.1016/s0014-5793(04)00073-0

Google Scholar

[6] C.A. Zhao, Zhao, X.D., Yu, H.G., Wu, Y.P., X.Q. Yang, 2003. Zhonghua Er. Ke. Za Zhi. Vol. 41(2003), p.594.

Google Scholar

[7] S.T. Crooke, Annu. Rev. Med. Vol. 55(2004), p.61.

Google Scholar

[8] S. Schubert, Furste, J.P., Werk, D., Grunert, H.P., Zeichhardt, H., Erdmann, V.A., J. Kurreck, J. Mol. Biol. 339(2004), Vol. p.355–363.

DOI: 10.1016/j.jmb.2004.03.064

Google Scholar

[9] R.M. Smith, G.Y. Wu, J. Viral Hepatitis Vol. 10(2003), p.405.

Google Scholar

[10] E.M. Westerhout, Ooms, M., Vink, M., Das, A.T., B. Berkhout, Nucleic Acids Res. Vol. 33(2005), p.796.

Google Scholar

[11] J.A. Wilson, C.D. Richardson, J. Virol. Vol. 79(2005), p.7050.

Google Scholar

[12] Y. Li and R.R. Breaker Curr Opin Struct Biol, Vol. 9(1999), p.315.

Google Scholar

[13] Y. Li, R.R. Breaker, Proc Natl Acad Sci USA,Vol. 96-6(1999), p.2746.

Google Scholar

[14] Y. Liu, R.R. Breaker, Biochemistry, Vol. 39(2000), p.3106.

Google Scholar

[15] N. Carmi, R. R, Breaker, Vol. 9(2001), p.2589.

Google Scholar

[16] R.R. Breaker, Science, Vol. 290(2000), p. (2095).

Google Scholar

[17] R.R. Breaker, Natl Biotechnol, Vol. 15(1997): p.427.

Google Scholar

[18] J. Alonso, J. Sasin, N. Bottini, et al. Cell, Vol. 117(2004): p.699.

Google Scholar

[19] J.N. Andersen, P.G. Jansen, S.M. Echwald, et al, FASEB, Vol. 18(2004), p.8.

Google Scholar

[20] T. Mustelin, G. S Feng, N. Bottini, Biosci, Vol. 7(2002), pp.85-142.

Google Scholar

[21] R.C. Aguiar, Y. Yakushijin, S. Kharbanda, et al. Vol. Blood. 94(1999), p.2403.

Google Scholar

[22] S. Avraham, R. London, G.A. Tulloch. Gene, Vol. 204 (1997), p.5.

Google Scholar

[23] T. Motiwala, H. Kutay, K. Ghoshal, Oncogene, Vol. 22(2003), p.6319.

Google Scholar

[24] T. Motiwala, H. Kutay,M. Ghoshal, Proc Natl Acad Sci USA, Vol. 101(2004), p.13844.

Google Scholar

[25] T. Mustelin, R. T Abraham, C.E. Rudd. Front. Biosci, Vol. 7(2002), p.918.

Google Scholar

[26] Y.J. You Y.P. Chen X.X. Zheng, H. Meltzer,H. Zhang, CancerLetters, Vol. 315(2012), p.138.

Google Scholar

[27] T. Motiwala, H. Kutay, K. Ghoshal, Jacob.S. T, Proc. Natl. Acad. Sci. Vol. 101 (2004) p.13844.

Google Scholar

[28] R.C. Aguiar, Y. Y Yakushijin, S Kharbanda, M.A. Shipp, Blood, Vol. 94 (1999) , p.2403.

Google Scholar

[29] T. Motiwala, S. Majumder, K. Ghoshal, S. T Jacob, J. Biol. Chem. Vol. 284 (2009) , p.455–464.

Google Scholar

[30] P.E. Thomas B.L. Wharram, M. Goyal, J.E. Wiggins, L. B Holzman, R.C. Wiggins, J. Biol. Chem. Vol. 269 (1994)p.19953.

DOI: 10.1016/s0021-9258(17)32113-0

Google Scholar

[31] T. Motiwala,K. Ghoshal,S. Majumder, S.T. Jacob,C. Plass, Oncogene, Vol. 22, (2003) , p.6319.

Google Scholar

[32] T. Motiwala, S. Majumder, H. Kutay, S.T. Jacob, Clin. Cancer Res. Vol. 13(2007) , p.3174.

Google Scholar

[33] B. Ramaswamy, S. Majumder, K. Ghoshal, C.L. Shapiro, S.T. Jacob, Mol. Endocrinol. Vol. 23 (2009) p.176.

Google Scholar